Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
The obvious question is
will we get an RNS at 700 so that the interview is actually an UNedited comment on the RNS?
IN CASE OF NO RNS they can easily edit out sensitive stuff
ShareBuyers
@sharebuyers
Our interview with Graham Mullis CEO of #NCYT will go live tomorrow. Merci beaucoup for your patience.
7:09 pm · 16 Feb 2021·Twitter Web App
hTtps://twitter.com/sharebuyers/status/1361754650693824519?s=21
The obvious question is
will we get an RNS at 700 so that the interview is actually an UNedited comment on the RNS?
IN CASE OF NO RNS they can easily edit out sensitive stuff
and filtered
guys you two, you are pathetic and I am afraid you missed the boat to buy cheap
well deserved, idiots
just jumped in with 10k at 2.99
fingers crossed and 5p by close ;-)
happy with 4 actually and then sky for limit
jrobbo , spot on
news of our TWO rapid tests could land any time
https://uk.advfn.com/stock-market/london/novacyt-NCYT/share-news/Novacyt-S-A-R-D-Update/83687114
QUOTE
Development of a LAMP COVID-19 test
L oop-mediated isothermal amplification ( LAMP ) technology is a single-tube technique for the amplification of DNA and RNA and is considered a low-cost alternative to detect certain diseases , including COVID-19. I sothermal amplification is carried out at a constant temperature without the need for a thermal cycler, contrast ing to PCR amplification, which is carried out with a series of alternating temperature steps or cycles in a thermal cycler .
Novacyt is currently developing a LAMP test for COVID-19, including evaluating the trade-off between cycle time and test performance . The Company expects to launch the product during Q1 2021 with an expected cycle time of 20 minutes or lower. Novacyt's LAMP offering is designed to be compatible with its q16 and q32 instruments . The Company is also in active discussions with several potential partners who are seeking support to develop, manufacture and supply LAMP tests for their instrument platforms.
Development of an antibody lateral flow test for COVID-19
On 29 September 2020, Novacyt announced the launch of its IgG specific antibody test for use in central laboratory testing. The Company is also working on developing an IgG antibody lateral flow test (LFT) for use as a rapid antibody test for professional use. An LFT is an easy-to-use diagnostic device used to confirm the presence or absence of a pathogen or biomarker. The product is expected to launch during Q1 2021 and is expected to take approximately 20 minutes or less to give a result.
UNQUOTE
sadly, I doubt, that irresponsible idiot will be visiting NCYT's labs, he visits those **** companies to endorse and promote his and Wancoc's LFT (Lateral Flawed Trash) choices, it is so obvious.
I hope to be totally wrong though. My average is 11£ :-(
https://coronavirus.data.gov.uk/
this is the only thing that counts (far right chart)
testing increasing relentlessly, despite everything else
and let's add this one:
htTps://coronavirus.data.gov.uk/
this is the only thing that counts (far right chart)
testing increasing relentlessly, despite everyhing else
statistically, the orders for our PCR tests must be increasing too, it must be inevitable
Ah! This is UK only and NHS only!
I guess this does not include UK airports and other private settings and , of course, the 120 countries we serll to.
The Company expects to launch the product during Q1 2021 with an expected cycle time of 20 minutes or lower."
news of our TWO rapid tests could land on Monday
hTtps://uk.advfn.com/stock-market/london/novacyt-NCYT/share-news/Novacyt-S-A-R-D-Update/83687114
QUOTE
Development of a LAMP COVID-19 test
Loop-mediated isothermal amplification ( LAMP ) technology is a single-tube technique for the amplification of DNA and RNA and is considered a low-cost alternative to detect certain diseases , including COVID-19. I sothermal amplification is carried out at a constant temperature without the need for a thermal cycler, contrast ing to PCR amplification, which is carried out with a series of alternating temperature steps or cycles in a thermal cycler .
Novacyt is currently developing a LAMP test for COVID-19, including evaluating the trade-off between cycle time and test performance . The Company expects to launch the product during Q1 2021 with an expected cycle time of 20 minutes or lower. Novacyt's LAMP offering is designed to be compatible with its q16 and q32 instruments . The Company is also in active discussions with several potential partners who are seeking support to develop, manufacture and supply LAMP tests for their instrument platforms.
Development of an antibody lateral flow test for COVID-19
On 29 September 2020, Novacyt announced the launch of its IgG specific antibody test for use in central laboratory testing. The Company is also working on developing an IgG antibody lateral flow test (LFT) for use as a rapid antibody test for professional use. An LFT is an easy-to-use diagnostic device used to confirm the presence or absence of a pathogen or biomarker. The product is expected to launch during Q1 2021 and is expected to take approximately 20 minutes or less to give a result.
UNQUOTE
thordon, I'd love to and I am very tempted, but just a bit nervous about little money in the bank and fear of a placement. I do not think I am unreasonable to consider this weakness. I am not a deramper at all.
nobody has my key point:
they have very little cash to operate
placement n dilution inevitable
quite shcoked to see it reached 8p! I loved itx in the past but i was severely hit when Shaw threatened to take it private. that was disgusting and I lost totally my trust. Now they have less and less cash in the bank and it will be inevitable to see another placement and dilution. Playing with fire material.
Am I missing something? I'd love to be proved wrong and come back.
YES YES YES , all good
and a 17% drop?
I am by far more disgusted by how poor the investors' relations department has (NOT) acted, highly responsible for what happened today. A great company, with no face, no brand. UNACCEPTABLE
WHAT DO WE KNOW ABOUT THE PHASE 2 OF THE NHS CONTRACTS!!!?? FA!!!!
I OWN PART OF THE COMPANY AND I HAVE THE ABSOLUTE RIGH TO KNOW
INTERESTING POINT, BUT 3000 shares is still a lot of money, 30k more or less. So, I would not call it small investors size
i agree, i tried the google translate trick, it does seem 19 january 2021!
I have just reported 1307
alexi and his 2017 plan?
hTtps://www.minexforum.com/en/venus-garden-holdings-is-planning-investment-in-the-west-kytlim-gold-and-platinum-mine-in-russia/
it is only ONE distributor!! 22 million ONE distributor, do you actually realise what that means!!!